NephroPlus IPO: Price band, lot size, and more
Nephrocare Health Services, a major name in India's dialysis scene, is opening its IPO from December 10-12, 2025, to raise up to ₹871 crore.
This includes a fresh issue of ₹353.4 crore and a share sale by existing investors like Investcorp and IFC.
What does the company do?
NephroPlus runs India's largest organized dialysis network, with 519 clinics globally—including locations in India, the Philippines, Uzbekistan, and Nepal.
Founded in 2009, it mainly serves chronic kidney disease patients—especially those in smaller cities.
Other details
The IPO price band is set at ₹438-460 per share; you'll need at least one lot of 32 shares to apply.
Allotments will be finalized on December 15 and shares list on BSE/NSE by December 17.
The company made ₹756 crore revenue with ₹67 crore profit in FY25; funds raised will help them expand further, pay off debt, and cover general expenses.
Promoters currently hold about 78.9% of the company.